Terms: = Pancreatic cancer AND ENO2, HEL-S-279, NSE AND Prognosis
18 results:
1. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract] [Full Text] [Related]
2. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
3. A New Anorectal Melanoma Cell Line Derived from a Primary Human Rectal Tumor.
Shinji S; Shichi Y; Yamada T; Takahashi G; Ohta R; Sonoda H; Matsuda A; Yonaga K; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Ueda Y; Sasaki N; Takahashi K; Ohashi R; Ishiwata T; Arai T; Yoshida H
J Nippon Med Sch; 2022 Aug; 89(4):368-376. PubMed ID: 35082206
[TBL] [Abstract] [Full Text] [Related]
4. Serum Biomarker Status with a Distinctive Pattern in prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
Zhang J; Cao Y; Zhang P; Zhang X; Li J; Zhou J; Wang X; Peng Z; Sun Y; Li J; Shen L; Lu M
Neuroendocrinology; 2022; 112(8):733-743. PubMed ID: 34592743
[TBL] [Abstract] [Full Text] [Related]
5. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
Zheng Y; Wu C; Yang J; Zhao Y; Jia H; Xue M; Xu D; Yang F; Fu D; Wang C; Hu B; Zhang Z; Li T; Yan S; Wang X; Nelson PJ; Bruns C; Qin L; Dong Q
Signal Transduct Target Ther; 2020 May; 5(1):53. PubMed ID: 32398667
[TBL] [Abstract] [Full Text] [Related]
6. The Feasibility of Serum Multiple Tumor Markers Test Between Patients with Primary pancreatic cancer and Those with Benign pancreatic Cystic Disease.
Lee JH
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625360
[TBL] [Abstract] [Full Text] [Related]
7. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
[TBL] [Abstract] [Full Text] [Related]
8. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
Liu F; Du F; Chen X
World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model.
Niedergethmann M; Alves F; Neff JK; Heidrich B; Aramin N; Li L; Pilarsky C; Grützmann R; Allgayer H; Post S; Gretz N
Br J Cancer; 2007 Nov; 97(10):1432-40. PubMed ID: 17940512
[TBL] [Abstract] [Full Text] [Related]
10. Solid cystic papillary tumor of pancreas in eight children.
Zhang KR; Jia HM; Shu H; Li XY
Chin Med Sci J; 2007 Mar; 22(1):54-7. PubMed ID: 17441319
[TBL] [Abstract] [Full Text] [Related]
11. Anaplastic carcinoma of the pancreas with squamous features: report of a case and immunohistochemical study.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takeyama H; Manabe T
Med Sci Monit; 2005 Nov; 11(11):CS65-8. PubMed ID: 16258403
[TBL] [Abstract] [Full Text] [Related]
12. Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas.
Nakamura Y; Tajiri T; Uchida E; Arima Y; Aimoto T; Katsuno A; Naito Z
J Hepatobiliary Pancreat Surg; 2005; 12(1):93-8. PubMed ID: 15754108
[TBL] [Abstract] [Full Text] [Related]
13. [A clinicopathological study of pancreatoblastoma].
He L; Li P; Liu S; Wang L; Liu N; Du X
Zhonghua Bing Li Xue Za Zhi; 1999 Oct; 28(5):337-9. PubMed ID: 11869544
[TBL] [Abstract] [Full Text] [Related]
14. A case of classical carcinoid tumor of the gallbladder: review of the Japanese published works.
Kaiho T; Tanaka T; Tsuchiya S; Miura M; Saigusa N; Yanagisawa S; Takeuchi O; Kitakata Y; Saito H; Shimizu A; Miyazaki M
Hepatogastroenterology; 1999; 46(28):2189-95. PubMed ID: 10521965
[TBL] [Abstract] [Full Text] [Related]
15. Neuroendocrine markers; chromogranin, pancreastatin and serotonin in the management of patients with advanced renal cell carcinoma.
Edgren M; Stridsberg M; Kalknar KM; Nilsson S
Anticancer Res; 1996; 16(6B):3871-4. PubMed ID: 9042273
[TBL] [Abstract] [Full Text] [Related]
16. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract] [Full Text] [Related]
17. Malignant papillary cystic tumor of the pancreas: report of a case and review of the literature.
Chu HW; Ho WL; Chang SM
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):139-44. PubMed ID: 1848136
[TBL] [Abstract] [Full Text] [Related]
18. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract] [Full Text] [Related]
